أرسل هذا في رسالة قصيرة: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

   _____     ___                 ___              
  / ___//   / _ \\      ___     / _ \\      ___   
  \___ \\  / //\ \\    /   ||  | / \ ||    /   || 
  /    // |  ___  ||  | [] ||  | \_/ ||   | [] || 
 /____//  |_||  |_||   \__ ||   \___//     \__ || 
`-----`   `-`   `-`     -|_||   `---`       -|_|| 
                         `-`                 `-`